Pyridoxamine Debate Prompts FDA Comment Period
This article was originally published in The Tan Sheet
Executive Summary
FDA tentatively has concluded that pyridoxamine is not a dietary supplement and has opened a 30-day comment period inviting information on the ingredient's prior marketing as a dietary ingredient or food